Validación del cuestionario RAPID3 en la cohorte argentina ESPAXIA de pacientes con espondiloartritis axial
Resumen
Introducción: El RAPID3 (Routine Assessment of Patient Index Data 3) es un cuestionario sencillo, rápido y de cálculo simple que mostró un buen rendimiento en Artritis Reumatoidea, siendo capaz de reflejar el estado de enfermedad y la calidad de vida en estos pacientes.Objetivo: Validar el cuestionario RAPID3 en una cohorte de pacientes con EsP axial y evaluar su asociación con otras medidas de evaluación de la enfermedad.Citas
I. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining dis-ease status in ankylosing spondylitis: the Bath Anky-losing Spondylitis Disease Activity Index. J Rheumatol 1994;21(12):2286-91.
II. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining func-tional ability in ankylosing spondylitis: the develop-ment of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21(12):2281-85.
III. Doward L, Spoorenberg A, Cook S, Whalley D, Helli-well P, Kay L, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spon-dylitis. Ann Rheum Dis 2003;62(1):20-6.
IV. Pincus T, Askanase AD, Swearingen CJ. A Multi-di-mensional Health Assessment Questionnaire (MD-HAQ) and routine assessment of patient index data (RAPID3) scores are informative in patients with all rheumatic diseases. Rheum Dis Clin North Am 2009;35(4):819-27.
V. Pincus T, Yazici Y, Sokka T. Complexities in assess-ment of rheumatoid arthritis: absence of a single gold standard measure. Rheum Dis Clin North Am 2009;35(4):687-97.
VI. Pincus T, Segurado O. An index based on only patient reported outcome (PRO) measures, without formal joint counts, routine assessment of patient index data (RAPID) classifies patients into 4 severity categories which are similar to Disease Activity Score (DAS28) and clinical Disease Activity Index (CDAI) catego-ries in 4 adalimumab clinical trials [abstract]. Arthritis Rheum 2007;56 Suppl:S705-6.
VII. Pincus T, Bergman MJ, Yazici Y, Hines P, Raghupathi K, Maclean R. An index of only patient-reported out-come measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: simi-lar results to disease activity score (DAS28) and other RAPID indices that include physician-reported mea-sures. Rheumatology (Oxford) 2008; 47(3):345-49.
VIII. Castrejón I, Bergman MJ, Pincus T. MDHAQ/RAP-ID3 to recognize improvement over 2 months in usual care of patients with osteoarthritis, systemic lupus ery-thematosus, spondyloarthropathy, and gout, as well as rheumatoid arthritis. Journal of Clinical Rheumatol-ogy. 2013;19(4):169-74.
IX. Maldonado Ficco H, Pérez Alamino R, Schneeberger EE, Maldonado Cocco JA, Citera G. Validación del cuestionario RAPID3 en una cohorte de pacientes con artritis reumatoidea temprana y establecida, y su co-rrelación con otros índices de actividad. Rev Argent Reumatol 2011;22 (2):31-39.
X. Citera G, Maldonado Cocco J, Moroldo M, Burgos-Vargas R, Anaya J, López I, et al Validación de la versión en español de los cuestionarios de capacidad funcional (BASFI) y actividad de la enfermedad (BAS-DAI) en pacientes con Espondilitis Anquilosante en cuatro países latinoamericanos. Rev Argent Reumatol 1999;10(Supl 1):25 [abstract].
XI. M arengo MF, Schneeberger EE, Citera G, Maldo-nado Cocco JA. Work status among patients with an-kylosing spondylitis in Argentina. J Clin Rheumatol 2008;14(5):273-7
XII. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewé R, van der Tempel H, Mielants H, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003; 62(2):131-36.
XIII. Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J, et al. Assessment of SpondyloArthritis inter-national Society et al. Development of an ASAS-en-dorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68(1):18-24.
XIV. Machado P, Landewé R, Lie E, Kvien TK, Braun J, Baker D, et al. Assessment of SpondyloArthritis inter-national Society et al. Ankylosing spondylitis disease activity score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 2011;70(1):47-53.
XV. Buschiazzo E, Sommerfleck F, Schneeberger EE, Ar-turi P, Maldonado Cocco JA, Citera G. Validación del índice ASDAS en una cohorte de pacientes con Es-pondilitis Anquilosante. Rev Arg Reumatol 2010;21:28.
XVI. Sommerfleck FA, Schneeberger EE, Buschiazzo EE, Maldonado Cocco JA, Citera G. A simplified version of ankylosing spondylitis disease activity score (AS-DAS) in patients with ankylosing spondylitis. Clin Rheumatol 2012;31(11):1599-603.
XVII. Salaffi F, Ciapetti A, Carotti M, Gasparini S, Citera G, Gutiérrez M. Construct validity and responsiveness of the simplified version of ankylosing spondylitis disease activity score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis. Health Qual Life Outcomes 2014;12:129.
XVIII. MacKay K, Mack C, Brophy S, Calin A. The Bath an-kylosing spondylitis radiology index (BASRI): A new, validated approach to disease assessment. Arthritis Rheum 1998;12(41): 2263-70.
XIX. Danve A, Reddy A, Vakil-Gilani K, Garg N, Dinno A, Deodhar A. Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath An-kylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritis. Clin Rheumatol 2015;34(1):117-24.
XX. Cinar M, Yilmaz S, Cinar FI, Koca SS, Erdem H, Pay S, et al. A patient-reported outcome measures-based composite index (RAPID3) for the assessment of dis-ease activity in ankylosing spondylitis. Rheumatol Int 2015;35(9):1575-80.
XXI. Park SH, Choe JY, Kim SK, Lee H, Castrejón I, Pin-cus T. Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Infor-mation in 85 Korean Patients With Ankylosing Spon-dylitis Seen in Usual Clinical Care. J Clin Rheumatol 2015;21(6):300-4.
XXII. Yokogawa N, Kaneko T, Nagai Y, Nunokawa T, Sawa-ki T, Shiroto K, et al. Validation of RAPID3 using a Japanese version of Multidimensional Health Assess-ment Questionnaire with Japanese rheumatoid arthri-tis patients: characteristics of RAPID3 compared to DAS28 and CDAI. Mod Rheumatol 2015;25(2):264-9.
XXIII. Singh H, Gupta V, Ray S, Kumar H, Talapatra P, Kaur M, et al. Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity In-dex (CDAI): an Indian experience. Clin Rheumatol 2012;31(12):1663-9.
XXIV. Kim SK, Park SH, Bae J, Son JT, Choe JY. Perfor-mance of Routine Assessment of Patient Index Data 3 (RAPID3) for assessment of rheumatoid arthritis in clinical practice: differential agreement of RAPID3 ac-cording to disease activity categories. Rheumatol Int 2014;34(9): 1311-8.
XXV. Yazici Y, Bergman M, Pincus T. Time to score quan-titative rheumatoid arthritis measures: 28-joint count, disease activity score, health assessment questionnaire (HAQ), multidimensional HAQ (MDHAQ), and rou-tine assessment of patient index data (RAPID) scores. J Rheumatol 2008;35(4):603-9.
Derechos de autor 2016 Sociedad Argentina de Reumatología
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-SinObrasDerivadas 4.0.
